La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action… — Class II drug recall D-0417-2025
Ongoing recall by L'Oreal USA, reported 2025-05-21, distributed nationwide. Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
| Recall number | D-0417-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | L'Oreal USA, Clark, NJ, United States |
| Recall initiated | 2025-03-05 |
| Classified | 2025-05-09 |
| Reported by FDA | 2025-05-21 |
| Distributed | Nationwide (US) |
| Quantity | 2,226,801 bottles |
| Reason classes | chemical contamination |
| UPC / GTIN / UDI-DI | 00883140500759 |
| Lot numbers | MYX46W |
| Expiration dates | 2025-04-30 |
Product
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
Reason for recall
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0417-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.